Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Design and synthesis of N-substituted indazole-3-carboxamides as poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors(†).

Patel MR, Pandya KG, Lau-Cam CA, Singh S, Pino MA, Billack B, Degenhardt K, Talele TT.

Chem Biol Drug Des. 2012 Apr;79(4):488-96. doi: 10.1111/j.1747-0285.2011.01302.x. Epub 2012 Jan 30.

PMID:
22177599
[PubMed - indexed for MEDLINE]
2.

(WO2011057959) indole and indazole derivatives as glycogen synthase activators: a patent evaluation.

Skaltsounis AL, Gaboriaud-Kolar N.

Expert Opin Ther Pat. 2011 Dec;21(12):1925-9. doi: 10.1517/13543776.2011.625406. Epub 2011 Oct 12. Review.

PMID:
21988345
[PubMed - indexed for MEDLINE]
3.

Poly(ADP-ribose)polymerase inhibition - where now?

Woon EC, Threadgill MD.

Curr Med Chem. 2005;12(20):2373-92. Review.

PMID:
16181138
[PubMed - indexed for MEDLINE]
4.

Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.

de la Lastra CA, Villegas I, Sánchez-Fidalgo S.

Curr Pharm Des. 2007;13(9):933-62. Review.

PMID:
17430191
[PubMed - indexed for MEDLINE]
5.

Poly(ADP-ribose) polymerase inhibitors.

Southan GJ, Szabó C.

Curr Med Chem. 2003 Feb;10(4):321-40. Review.

PMID:
12570705
[PubMed - indexed for MEDLINE]
6.

PARP inhibitors: new tools to protect from inflammation.

Giansanti V, Donà F, Tillhon M, Scovassi AI.

Biochem Pharmacol. 2010 Dec 15;80(12):1869-77. doi: 10.1016/j.bcp.2010.04.022. Epub 2010 Apr 22. Review.

PMID:
20417190
[PubMed - indexed for MEDLINE]
7.

The Davis-Beirut Reaction: a novel entry into 2H-indazoles and indazolones. Recent biological activity of indazoles.

Haddadin MJ, Conrad WE, Kurth MJ.

Mini Rev Med Chem. 2012 Oct;12(12):1293-300. Review.

PMID:
23092440
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk